SPOTLIGHT -
Slideshow
Author(s):
Depression predominates across the lifespan in patients with bipolar disorder. Here: A discussion about (and beyond) the four FDA-approved drugs to treat symptoms.
Investigating the SAINT iTBS Protocol for Bipolar I Depression
Blue Light Blockers: A Behavior Therapy for Mania
Online Survey Reveals Clinicians’ Top Concerns in BDI, Schizophrenia Treatment
Blue Light, Depression, and Bipolar Disorder
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia
When the Fog Doesn’t Lift: Targeting Cognitive Dysfunction in Depression